Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pharmaxis Ltd ( (AU:SNT) ) has shared an update.
Syntara Limited has announced a change in the director’s interest notice, specifically involving Waradana Malitha Hashan De Silva, who is a managing partner of the manager of the KP Rx Healthcare Trust. The trust, through AMAL Security Services Pty Ltd, acquired 9,753,442 ordinary shares at $0.06 per share, increasing the total shares held indirectly by the trust to 63,324,871. This acquisition was part of a placement of ordinary shares approved by shareholders, potentially impacting the company’s market positioning by increasing its shareholding structure.
More about Pharmaxis Ltd
YTD Price Performance: -7.50%
Average Trading Volume: 3,674,631
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$118.5M
Learn more about SNT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue